• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Health plans must scrutinize contracts

Article

A recent Supreme Court Decision underscores the necessity of counsel reviewing the dispute resolution terms in health plan contracts with providers

A recent Supreme Court Decision underscores the necessity of counsel reviewing the dispute resolution terms in health plan contracts with providers. In Oxford Health Plans LLC v. JohnIvan Sutter (2013 WL 2459522 (U.S.)), the Court held that an arbitrator did not exceed his powers in authorizing a class arbitration, despite Oxford’s assertion that he acted outside the scope of his delegated authority.

Sutter, a pediatrician, provided medical services to Oxford Health Plans’ insureds under a fee-for-service contract that required binding arbitration of contractual disputes. After several years of working under contract with Oxford, Sutter filed suit against Oxford in New Jersey Superior Court on behalf of himself and a proposed class of other New Jersey physicians under contract with Oxford. The complaint alleged that Oxford had failed to make prompt payment to the doctors in violation of their agreements and various state laws.

Oxford moved to compel arbitration of Sutter’s claims, relying on a clause in their contract that prohibited civil actions such as this being brought before any court, but rather “shall be submitted to final and binding arbitration in New Jersey, pursuant to the rules of the American Arbitration Association with one arbitrator.” The state court granted Oxford’s motion, thus referring the suit to arbitration.

The parties agreed that the arbitrator should decide whether their contract authorized class arbitration, and he determined that it did. Noting that the question turned on the construction of the parties’ agreement, the arbitrator focused on the text of the clause, and he reasoned that the clause sent to arbitration the same “universal class of disputes” that it barred the parties from bringing as civil actions in court.

Oxford filed a motion in federal court to vacate the arbitrator’s decision on the grounds that he had exceeded his powers under § 10(a)(4) of the FAA. The District Court denied the motion, and the Court of Appeals for the Third Circuit affirmed.

While the arbitration proceeded, the Supreme Court held in Stolt-Nielson S.A. v. AnimalFeedsInt’l Corp., 559 U.S. 662, 130 S.Ct. 1758, 176 L.Ed.2d 605, that an arbitrator may employ class procedures only if the parties have authorized them. In contrast to the Oxford proceedings, the parties in Stolt-Nielson had stipulated that they had never reached an agreement on class arbitration. Oxford immediately asked the arbitrator to re-consider, a request based on what appears to be a misunderstanding of the Supreme Court’s holding. The arbitrator issued a new opinion, holding that Stolt-Nielson had no effect on the case because the Oxford agreement did authorize class arbitration.

The Supreme Court’s holding illustrates the stark contrast between Stolt-Nielson and the Oxford proceeding. In the former, the Court found that the arbitrators did not construe the parties’ contract and did not identify any agreement authorizing class proceedings. When the Court set aside the arbitrator’s decision, they did so not because the contract was misinterpreted by the arbitrator, but rather because the arbitrator had abandoned his interpretive role. In Oxford, the Court finds that the arbitrator did construe the contract and found in it an agreement to permit class proceedings. But, as the Court explains, to overturn the arbitrator’s decision, they would need to rely on a finding that the arbitrator misapprehended the parties’ intent.  However, §10(a)(4) bars that path: it permits courts to vacate an arbitral decision only when the arbitrator strayed from his delegated task of interpreting a contract, not when he performed the task poorly.

Related Videos
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Related Content
© 2024 MJH Life Sciences

All rights reserved.